161 related articles for article (PubMed ID: 38203669)
1. An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 Reporter.
Lai J; Shang C; Chen W; Izevbaye I; Chu MP; Sandhu I; Brandwein J; Lai R; Wang P
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203669
[TBL] [Abstract][Full Text] [Related]
2. ULK2 Is a Key Pro-Autophagy Protein That Contributes to the High Chemoresistance and Disease Relapse in FLT3-Mutated Acute Myeloid Leukemia.
Lai J; Yang C; Shang C; Chen W; Chu MP; Brandwein J; Lai R; Wang P
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203816
[TBL] [Abstract][Full Text] [Related]
3. Identification and Characterization of Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma Using the SORE6 Reporter.
Li J; Haque M; Shang C; Hassan B; Liu D; Chen W; Lai R
Curr Issues Mol Biol; 2021 Jul; 43(2):543-557. PubMed ID: 34287231
[TBL] [Abstract][Full Text] [Related]
4. A SOX2 Reporter System Identifies Gastric Cancer Stem-Like Cells Sensitive to Monensin.
Pádua D; Barros R; Amaral AL; Mesquita P; Freire AF; Sousa M; Maia AF; Caiado I; Fernandes H; Pombinho A; Pereira CF; Almeida R
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32093282
[TBL] [Abstract][Full Text] [Related]
5. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
[No Abstract] [Full Text] [Related]
6. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
te Boekhorst PA; Löwenberg B; Sonneveld P
Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289
[TBL] [Abstract][Full Text] [Related]
7. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
[TBL] [Abstract][Full Text] [Related]
8. Elimination of SOX2/OCT4-Associated Prostate Cancer Stem Cells Blocks Tumor Development and Enhances Therapeutic Response.
Vaddi PK; Stamnes MA; Cao H; Chen S
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31500347
[TBL] [Abstract][Full Text] [Related]
9. The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05R study.
Moritake H; Tanaka S; Miyamura T; Nakayama H; Shiba N; Shimada A; Terui K; Yuza Y; Koh K; Goto H; Kakuda H; Saito A; Hasegawa D; Iwamoto S; Taga T; Adachi S; Tomizawa D
Pediatr Blood Cancer; 2021 Jan; 68(1):e28736. PubMed ID: 32991072
[TBL] [Abstract][Full Text] [Related]
10. DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant.
Dillon LW; Gui G; Page KM; Ravindra N; Wong ZC; Andrew G; Mukherjee D; Zeger SL; El Chaer F; Spellman S; Howard A; Chen K; Auletta J; Devine SM; Jimenez Jimenez AM; De Lima MJG; Litzow MR; Kebriaei P; Saber W; Weisdorf DJ; Hourigan CS
JAMA; 2023 Mar; 329(9):745-755. PubMed ID: 36881031
[TBL] [Abstract][Full Text] [Related]
11. SOX2 Expression and Transcriptional Activity Identifies a Subpopulation of Cancer Stem Cells in Sarcoma with Prognostic Implications.
Menendez ST; Rey V; Martinez-Cruzado L; Gonzalez MV; Morales-Molina A; Santos L; Blanco V; Alvarez C; Estupiñan O; Allonca E; Rodrigo JP; García-Castro J; Garcia-Pedrero JM; Rodriguez R
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32295077
[TBL] [Abstract][Full Text] [Related]
12. French Retrospective Database Analysis of Patient Characteristics and Treatment Patterns in Patients with R/R FLT3-Mutated AML: A Registry-Based Cohort Study.
Garnham A; Bruon F; Berthon C; Lebon D; Parimi M; Polya R; Makhloufi KM; Dramard-Goasdoue MH
Oncol Ther; 2023 Sep; 11(3):375-389. PubMed ID: 37578642
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia.
Fleischmann M; Scholl S; Frietsch JJ; Hilgendorf I; Schrenk K; Hammersen J; Prims F; Thiede C; Hochhaus A; Schnetzke U
J Cancer Res Clin Oncol; 2022 Nov; 148(11):3191-3202. PubMed ID: 35099591
[TBL] [Abstract][Full Text] [Related]
14. FLT3 mutations at diagnosis and relapse in acute myeloid leukemia: cytogenetic and pathologic correlations, including cuplike blast morphology.
McCormick SR; McCormick MJ; Grutkoski PS; Ducker GS; Banerji N; Higgins RR; Mendiola JR; Reinartz JJ
Arch Pathol Lab Med; 2010 Aug; 134(8):1143-51. PubMed ID: 20670134
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous patterns of FLT3 Asp(835) mutations in relapsed de novo acute myeloid leukemia: a comparative analysis of 120 paired diagnostic and relapse bone marrow samples.
Shih LY; Huang CF; Wu JH; Wang PN; Lin TL; Dunn P; Chou MC; Kuo MC; Tang CC
Clin Cancer Res; 2004 Feb; 10(4):1326-32. PubMed ID: 14977832
[TBL] [Abstract][Full Text] [Related]
17. FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotype.
Wagner K; Damm F; Thol F; Göhring G; Görlich K; Heuser M; Schäfer I; Schlegelberger B; Heil G; Ganser A; Krauter J
Haematologica; 2011 May; 96(5):681-6. PubMed ID: 21242187
[TBL] [Abstract][Full Text] [Related]
18. Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of Literature.
Arrigo G; D'Ardìa S; Audisio E; Cerrano M; Freilone R; Giai V; Secreto C; Urbino I; Frairia C
Acta Haematol; 2022; 145(5):566-570. PubMed ID: 35580565
[TBL] [Abstract][Full Text] [Related]
19. Prognostication refinement in NPM1-mutated acute myeloid leukemia stratified by FLT3-ITD status with different induction doses of cytarabine.
Wang B; Hua X; Zhang J; Gu W; Li H
Cancer Med; 2023 Apr; 12(8):9420-9433. PubMed ID: 36808479
[TBL] [Abstract][Full Text] [Related]
20. [Variables associated with hematological remission and survival in patients with acute myeloid leukemia after induction failure and relapse].
Ma YR; Zhao T; Ma L; Hu LJ; Duan WB; Jiang H; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2022 Aug; 43(8):644-650. PubMed ID: 36709148
[No Abstract] [Full Text] [Related]
[Next] [New Search]